The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A

PLoS ONE

Volumn 2, Issue 6, 2007, Pages

  Zhang, Shiping ^a   McCormack, Francis X ^a   Levesque, Roger C ^b   O'Toole, George A ^c   Lau, Gee W ^d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITÉ LAVAL   (Canada)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; FLAGELLAR HOOK PROTEIN; FLGE PROTEIN; FLIC PROTEIN; SURFACTANT PROTEIN A; UNCLASSIFIED DRUG; FLGE PROTEIN, BACTERIA; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL FLAGELLUM; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; LUNG CLEARANCE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE; WILD TYPE; ANIMAL; C3H MOUSE; CELL MEMBRANE PERMEABILITY; CYTOLOGY; FLAGELLUM; GENETICS; ISOLATION AND PURIFICATION; LUNG; LUNG ALVEOLUS MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; MUTATION; NEUTROPHIL; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; PSEUDOMONAS INFECTION; WESTERN BLOTTING;

BACTERIA (MICROORGANISMS); MUS; PSEUDOMONAS AERUGINOSA;

ANIMALS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CELL MEMBRANE PERMEABILITY; CYSTIC FIBROSIS; FLAGELLA; HUMANS; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MUTATION; NEUTROPHILS; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A;

EID: 35348924188     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000564     Document Type: Article

References (54)

1. Soutourina OA, Bertin PN (2003) Regulation cascade of flagellar expression in Gram-negative bacteria. FEMS Microbiol Rev 27: 505-523.
2. Zeng H, Carlson AQ, Guo Y, Yu Y, Collier-Hyams LS, et al. (2003) Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol 171: 3668-3674.
3. Feldman M, Bryan R, Rajan S, Scheffler L, Brunnert S, et al. (1998) Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun 66: 43-51.
4. Mahenthiralingam E, Campbell ME, Speert DP (1994) Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62: 596-605.
5. Mahenthiralingam E, Speert DP (1995) Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum. Infect Immun 63: 4519-4523.
6. Wolfgang MC, Jyot J, Goodman AL, Ramphal R, Lory S (2004) Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc Natl Acad Sci USA 101: 6664-6668.
7. Tart AH, Blanks MJ, Wozniak DJ (2006) The AlgT-dependent transcriptional regulator AmrZ (AlgZ) inhibits flagellum biosynthesis in mucoid, nonmotile Pseudomonas aeruginosa cystic fibrosis isolates. J Bacteriol 188: 6483-6489.
8. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, et al. (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103.
9. Lau GW, Hassett DJ, Britigan BE (2005) Modulation of lung epithelial functions by Pseudomonas aeruginosa. Trends Microbiol 13: 389-397.
10. Hawgood S, Shifler K (1991) Structures and properties of the surfactant-associated proteins. Annu Rev Physiol 53: 375-394.
11. Wright JR (2005) Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5: 58-68.
12. Crouch E, Wright JR (2001) Surfactant proteins a and d and pulmonary host defense. Annu Rev Physiol 63: 521-554.
13. Crowther JE, Kutala VK, Kuppusamy P, Ferguson JS, Beharka AA, et al. (2004) Pulmonary surfactant protein A inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J Immunol 172: 6866-6874.
14. Gaynor CD, McCormack FX, Voelker DR, McGowan SE, Schlesinger LS (1995) Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 155: 5343-5351.
15. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, et al. (2003) Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 111: 1589-1602.
16. Schaeffer LM, McCormack FX, Wu H, Weiss AA (2004a) Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A. J Immunol 173: 1959-1965.
17. Zhang S, Chen Y, Potvin E, Sanschagrin F, Levesque RC, et al. (2005) Comparative signature-tagged mutagenesis identifies Pseudmonas factors conferring resistance to the pulmonary collectin SP-A. PLoS Pathog 1: 259-268.
18. Kuzmenko AI, Wu H, McCormack FX (2096) Pulmonary collectins selectively permeabilize model bacterial membranes containing rough lipopolysaccharide. Biochemistry 45: 2679-2685.
19. Potvin E, Lehoux DE, Kukavica-Ibrulj I, Richard KI, Sanschagrin F, et al. (2003) In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets. Environ Microbiol 5: 1294-1308.
20. Bren A, Eisenbach M (2000) How signals are heard during bacterial chemotaxis: protein-protein interactions in sensory signal propagation. J Bacteriol 182: 6865-6873.
21. Lau GW, Ran H, Kong F, Hassett DJ, Mavrodi D (2004) Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun 72: 4275-4278.
22. Hartshorn KL, Crouch E, White MR, Colamussi ML, Kakkanatt A, et al. (1998) Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol 274: L958-L969.
23. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, et al. (1998) Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 19: 700-708.
24. Mariencheck WI, Savov J, Dong Q, Tino MJ, Wright JR (1999) Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of Pseudomonas aeruginosa. Am J Physiol 277: L777-L786.
25. McCormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H, Deepe GS Jr (2003) Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 278: 36250-36256.
26. Arora SK, Ritchings BW, Almira EC, Lory S, Ramphal R (1998) The Pseudomonas aeruginosa flagellar cap protein, FliD, is responsible for mucin adhesion. Infect Immun 66: 1000-1007.
27. Fleiszig SM, Arora SK, Van R, Ramphal R (2001) FlhA, a component of the flagellum assembly apparatus of Pseudomonas aeruginosa, plays a role in internalization by corneal epithelial cells. Infect Immun 69: 4931-4937.
28. Boyce JR, Miller RV (1982) Motility as a selective force in the reversion of cystic fibrosis-associated mucoid Pseudomonas aeruginosa to the nonmucoid phenotype in culture. Infect Immun 37: 840-844.
29. Toutain CM, Zegans ME, O'Toole CA (2005) Evidence for two flagellar stators and their role in the motility of Pseudomonas aeruginosa. J Bacteriol 187: 771-777.
30. Kojima S, Blair DF (2001) Conformational change in the stator of the bacterial flagellar motor. Biochemistry 40: 13041-13050.
31. Harshey RM (2003) Bacterial motility on a surface: many ways to a common goal. Annu Rev Microbiol 57: 249-273.
32. O'Toole GA, Kolter R (1998) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30: 295-304.
33. Kim W, Killam T, Sood V, Surette MG (2003) Swarm-cell differentiation in Salmonella enterica serovar typhimurium results in elevated resistance to multiple antibiotics. J Bacteriol 185: 3111-3117.
34. Mah TF, O'Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9: 34-39.
35. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, et al. (2003) A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426: 306-310.
36. Lyczak JB, Cannon CL, Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15: 194-222.
37. Rocchetta HL, Burrows LL, Lam JS (1999) Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 63: 523-553.
38. Baughman RP, Sternberg RI, Hull W, Buchsbaum JA, Whitsett J (1993) Decreased surfactant protein A in patients with bacterial pneumonia. Am Rev Respir Dis 147: 653-657.
39. Griese M, Birrer P, Demitsoy A (1997) Pulmonary surfactant in cystic fibrosis. Eur Respir J 10: 1983-1988.
40. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, et al. (1996) Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153: 176-184.
41. Rubio F, Cooley J, Accurso FJ, Remold-O'Donnell E (2004) Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease. Thorax 59: 318-323.
42. Mariencheck WI, Alcorn JF, Palmer SM, Wright JR (2003) Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. Am J Respir Cell Mol Biol 28: 528-537.
43. Malloy JL, Veldhuizen RA, Thibodeaux BA, O'Callaghan RJ, Wright JR (2005) Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am J Physiol Lung Cell Mol Physiol 288: L409-L418.
44. Singh PK, Tack BF, McCray PB Jr, Welsh MJ (2000) Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol 279: L799-L805.
45. Yan H, Hancock RE (2001) Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob Agents Chemother 45: 1558-1560.
46. Holloway BW, Krishnapillai V, Morgan AF (1979) Chromosomal genetics of Pseudomonas. Microbiol Rev 43: 73-102.
47. Dasgupta N, Wolfgang MC, Goodman AL, Arora SK, Jyot J, et al. (2003) A four-tiered transcriptional. regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa. Mol Microbiol 50: 809-824.
48. Rahme LG, Stevens FJ, Wolfort SF, Shao J, Tompkins RG, et al. (1995) Common virulence factors for bacterial pathogenicity in plants and animals. Science 268: 1899-1902.
49. Arora SK, Neely AN, Blair B, Lory S, Ramphal R (2005) Role of motility and flagellin glycosylation in the pathogenesis of Pseudomonas aeruginosa burn wound infections. Infect Immun 73: 4395-4398.
50. Suwabe A, Mason RJ, Voelker DR (1996) Calcium dependent association of surfactant protein A with pulmonary surfactant: application to simple surfactant protein A purification. Arch Biochem Biophys 327: 285-291.
51. Kratochvil B, White MC (1965) Spectrophotometric determination of microgram quantities of (ethylenedinitrilo)tetraacetic acid with bis(2,4,6-tripyridyl-S- triazine)iron(II) Anal Chem 37: 111-113:
52. Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, et al. (1996) Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 93: 9594-9599.
53. Newman SL, Gootee L, Gabay JE (1993) Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules. J Clin Invest 92: 624-631.
54. Kong F, Young L, Chen Y, Ran H, Meyers M, Joseph P, Cho YH, Hassett DJ, Lau GW (2006) Pseudomonas aeruginosa pyocyanin inactivates lung epithelial vacuolar ATPase-dependent cystic fibrosis transmembrane conductance regulator expression and localization. Cell Microbiol 8: 1121-1133.